LeVert Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Upstreambiotechupstreambiotech.comSep 2025
Upstream Biotechnology develops RNA-based seed traits that regulate crop immune defenses at the gene-expression level, activating disease and stress responses only in the affected tissue to limit yield drag.
AgTechBiotechClimate TechDurham, US
George H. Greene(Executive Officer, Director)Xiao-fang Wang(Director)Xinnian Dong(Director)
Board seatKaren LeVert· per SEC Form D
Co-investorsAg Ventures AllianceAgLaunch AcceleratorMiddleland CapitalRedstick Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.